Notice of Intent To Grant Exclusive License, 41203 [2012-17017]

Download as PDF Federal Register / Vol. 77, No. 134 / Thursday, July 12, 2012 / Notices Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. ADDRESSES: Objections relating to the prospective license may be submitted to Mr. James J. McGroary, Chief Patent Counsel/LS01, Marshall Space Flight Center, Huntsville, AL 35812, Telephone: (256) 544–0013; Facsimile: (256) 544–0258. FOR FURTHER INFORMATION CONTACT: Mr. Sammy A. Nabors, Technology Transfer Office/ZP30, Marshall Space Flight Center, Huntsville, AL 35812, Telephone: (256) 544–5226; Facsimile: (256) 544–0258. Information about other NASA inventions available for licensing can be found online at https:// technology.nasa.gov. Sumara M. Thompson-King, Acting Deputy General Counsel. [FR Doc. 2012–17016 Filed 7–11–12; 8:45 am] BILLING CODE 7510–13–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice 12–041] Notice of Intent To Grant Exclusive License National Aeronautics and Space Administration. ACTION: Notice of Intent to Grant Exclusive Research Only License. AGENCY: This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license in the United States to practice the invention described and claimed in U.S. Patent Nos. 7,113,820 entitled, ‘‘Real-Time, High Frequency QRS Electrocardiograph,’’ 7,539,535 entitled, ‘‘Real-Time, High Frequency QRS Electrocardiograph with Reduced Amplitude Zone Detection,’’ and 7,386,340 entitled, ‘‘System for Diagnosis and Monitoring of Coronary Artery Disease, Acute Coronary Artery Syndromes, Cardiomyopathy and Other Cardiac Conditions,’’ to Medcare Holdings, LTD, having its principal place of business at P.O. Box 3483, Road Town, Tortola, British Virgin Islands. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. pmangrum on DSK3VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:39 Jul 11, 2012 Jkt 226001 The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. ADDRESSES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of the Chief Counsel, NASA Johnson Space Center, 2101 NASA Parkway, Mail Code AL, Houston, TX 77058; Phone (281) 483– 3021; Fax (281) 483–6936. FOR FURTHER INFORMATION CONTACT: Ted Ro, Intellectual Property Attorney, Office of Chief Counsel, NASA Johnson Space Center, 2101 NASA Parkway, Mail Code AL, Houston, TX 77058; Phone (281) 244–7148; Fax (281) 483– 6936. Information about other NASA inventions available for licensing can be found online at https:// technology.nasa.gov/. DATES: Sumara M. Thompson-King, Acting Deputy General Counsel. [FR Doc. 2012–17017 Filed 7–11–12; 8:45 am] BILLING CODE 7510–13–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice 12–057] NASA International Space Station Advisory Committee; Meeting National Aeronautics and Space Administration (NASA). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, Public Law 92–463, as amended, the National Aeronautics and Space Administration announces an open meeting of the NASA International Space Station (ISS) Advisory Committee. The purpose of the meeting is to assess NASA and Roscosmos continuing plans to support a six-person crew aboard the International Space Station, including transportation, and crew rotation; and, SUMMARY: PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 41203 to assess the possibilities for using the ISS for future space exploration. August 28, 2012, 1–2 p.m. Eastern Daylight Time. DATES: NASA Headquarters, 300 E Street SW., Glennan Conference Room, 1Q39, Washington, DC 20546. ADDRESSES: Dr. J. Donald Miller, Office of International and Interagency Relations, (202) 358– 1527, National Aeronautics and Space Administration, Washington, DC 20546– 0001. FOR FURTHER INFORMATION CONTACT: It is imperative that the meeting be held on this date to accommodate the scheduling priorities of the key participants. This meeting will be open to the public up to the seating capacity of the room. Attendees will be requested to sign a register and to comply with NASA security requirements, including the presentation of a valid picture ID, before receiving an access badge. Foreign nationals attending this meeting will be required to provide a copy of their passport, visa, or green card in addition to providing the following information no less than ten working days prior to the meeting: Full name; gender; date/place of birth; citizenship; visa/green card information (number, type, expiration date); passport information (number, country, expiration date); employer/affiliation information (name of institution, address, country, phone); title/position of attendee, and an electronically scanned or faxed copy of their passport and visa. Send identifying information to Dr. Miller via email at j.d.miller@nasa.gov or by telephone at (202) 358–1527 or fax (202) 358–3030. To expedite admittance, attendees with U.S. citizenship or a green card may provide their full name, company affiliation (if applicable), and citizenship three working days in advance by contacting Dr. Miller via email at j.d.miller@nasa.gov or by telephone at (202) 358–1527. SUPPLEMENTARY INFORMATION: Patricia D. Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. 2012–17037 Filed 7–11–12; 8:45 am] BILLING CODE 7510–13–P E:\FR\FM\12JYN1.SGM 12JYN1

Agencies

[Federal Register Volume 77, Number 134 (Thursday, July 12, 2012)]
[Notices]
[Page 41203]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17017]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 12-041]


Notice of Intent To Grant Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Intent to Grant Exclusive Research Only License.

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and 
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant 
an exclusive license in the United States to practice the invention 
described and claimed in U.S. Patent Nos. 7,113,820 entitled, ``Real-
Time, High Frequency QRS Electrocardiograph,'' 7,539,535 entitled, 
``Real-Time, High Frequency QRS Electrocardiograph with Reduced 
Amplitude Zone Detection,'' and 7,386,340 entitled, ``System for 
Diagnosis and Monitoring of Coronary Artery Disease, Acute Coronary 
Artery Syndromes, Cardiomyopathy and Other Cardiac Conditions,'' to 
Medcare Holdings, LTD, having its principal place of business at P.O. 
Box 3483, Road Town, Tortola, British Virgin Islands. The patent rights 
in these inventions have been assigned to the United States of America 
as represented by the Administrator of the National Aeronautics and 
Space Administration. The prospective exclusive license will comply 
with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective exclusive license may be granted unless, within 
fifteen (15) days from the date of this published notice, NASA receives 
written objections including evidence and argument that establish that 
the grant of the license would not be consistent with the requirements 
of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and 
received by NASA within fifteen (15) days of the date of this published 
notice will also be treated as objections to the grant of the 
contemplated exclusive license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of the Chief Counsel, NASA Johnson 
Space Center, 2101 NASA Parkway, Mail Code AL, Houston, TX 77058; Phone 
(281) 483-3021; Fax (281) 483-6936.

FOR FURTHER INFORMATION CONTACT: Ted Ro, Intellectual Property 
Attorney, Office of Chief Counsel, NASA Johnson Space Center, 2101 NASA 
Parkway, Mail Code AL, Houston, TX 77058; Phone (281) 244-7148; Fax 
(281) 483-6936. Information about other NASA inventions available for 
licensing can be found online at https://technology.nasa.gov/.

Sumara M. Thompson-King,
Acting Deputy General Counsel.
[FR Doc. 2012-17017 Filed 7-11-12; 8:45 am]
BILLING CODE 7510-13-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.